BioPharmX Corp company info

CIK 1504167
IRS Number 593843182
State of incorporation DE
Business address 1505 ADAMS DRIVE, SUITE D
None
MENLO PARK
CA
94025
Mail address 1505 ADAMS DRIVE, SUITE D
None
MENLO PARK
CA
94025

Short summary

BioPharmX Corp is a California company, with head office located at 1505 Adams Drive, Suite D Menlo Park, California 94025. In 2018 the company owned a total of 7.43 million USD worth of assets, including 7.29 million USD worth of current assets. 2017 was the year when the company amassed the most assets.

BioPharmX Corp Income Statement

Name [in Millions USD]201020112012201320142015201620172018Trends
Revenue, Net 0.060.100.07
Gross Profit -0.17-0.42-0.18
Research and development 0.030.672.525.7010.169.14
Operating Expenses 0.060.081.517.7714.9918.0116.70
Operating Income (Loss) -0.06-0.03-1.51-7.77-15.16-18.43-16.88
Interest expense 0.010.070.080.15
Other Nonoperating Income (Expense) 0.04-0.44-0.14-0.13
Income Tax Expense (Benefit) 0.000.000.00
Net income -0.06-0.09-1.59-7.81-15.60-18.41-16.64

BioPharmX Corp Balance Sheet

Name [in Millions USD]201020112012201320142015201620172018Trends
Cash and cash equivalents 0.010.000.000.870.484.046.7110.936.58
Accounts Receivable, Net, Current 0.010.010.000.010.02
Inventories 0.220.080.030.010.01
Property, Plant and Equipment, Gross 0.000.010.060.270.300.200.24
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.000.000.010.030.090.080.13
Intangible Assets, Net (Excluding Goodwill) 0.150.140.110.10
Other Assets, Noncurrent 0.150.050.050.150.15
Total assets 0.020.000.001.651.834.817.2511.447.43
Current assets 0.020.000.001.261.374.436.9811.287.29
Non-current assets 0.150.05
Accounts payable 0.231.782.392.311.791.53
Total current liabilities 0.010.060.071.192.673.344.083.073.05
Long-term Debt 2001.65
Total liabilities 0.081.191.562.804.853.213.17
Common Stock, Value, Issued 0.010.010.010.010.010.030.070.190.19
Retained Earnings (Accumulated Deficit) -1.68-14.26-30.69-50.04-65.68-70.09

BioPharmX Corp Cash Flow

Name [in Millions USD]201020112012201320142015201620172018Trends
Net income -0.06-0.09-1.59-7.81-15.60-18.41-16.64
Depreciation 0.000.000.010.030.060.140.05
Accounts receivable 0.000.01-0.000.00
Inventories 0.14-0.06-0.06-0.03
Deferred revenue 0.01
Net Cash Provided by (Used in) Operating Activities -0.01-0.05-1.08-15.75-15.59
Payments to Acquire Property, Plant, and Equipment 0.000.010.030.230.040.050.04
Payments to Acquire Intangible Assets 0.06
Net Cash Provided by (Used in) Investing Activities -0.00-0.01-0.09-0.05-0.04
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.09-0.26-0.04-0.05
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.100.080.04
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.100.080.04
Proceeds from Issuance of Common Stock 0.1013.32
Net Cash Provided by (Used in) Financing Activities 0.020.201.0318.2516.70
Cash and Cash Equivalents, Period Increase (Decrease) 0.14-0.142.112.732.461.08